IL-17 is widely expressed in portal regions, with evident inflammatory cell infiltration in liver tissues of patients with AIH (112), PBC (113), and overlap syndrome (114), and it is considered a significant proinflammatory and profibrotic agent in the liver (115, 116). The gene discussed is IL17A; the disease is primary biliary cholangitis.